U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT06905314) titled 'A Single Ascending Dose of HRS-4029 in Healthy Subjects' on March 25.

Brief Summary: The study is being conducted to evaluate the safety, tolerability and pharmacokinetics of HRS-4029 following a single intravenous dose administration in healthy subjects.

Study Start Date: April, 2025

Study Type: INTERVENTIONAL

Condition: Acute Ischemic Stroke

Intervention: DRUG: HRS-4029

HRS-4029

DRUG: Placebo

Placebo

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd

Published by HT Digital Content Services with permission from Health Daily Digest....